EP Patent

EP3668527A1 — Compositions and methods for treating cholestatic disease

Assigned to Seres Therapeutics Inc · Expires 2020-06-24 · 6y expired

What this patent protects

The invention relates to compositions and methods used in the treatment and prevention of cholestatic disease.

USPTO Abstract

The invention relates to compositions and methods used in the treatment and prevention of cholestatic disease.

Drugs covered by this patent

balsalazide-disodium (BALSALAZIDE DISODIUM)

Patent Metadata

Patent number: EP3668527A1
Jurisdiction: EP
Classification: —
Expires: 2020-06-24
Drug substance claim: No
Drug product claim: No
Assignee: Seres Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.